TrialPloS one2014

MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial.

Thomas Pavelitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.